Friday, 10 Apr 2020

You are here

Why You Should Come to RheumNow Live March 13th

RheumNow Live kicks off its second annual meeting - a little, big meeting in Fort Worth - in just 2 weeks and I think you should be there.

This 17.25 CME credit hour meeting runs from Friday afternoon (3/13) until Sunday morning (3/15), meaning you can drop in over a short weekend and see some of the best lectures and interactive educational sessions you've ever attended.

This is the little big meeting because Artie Kavanaugh and I wanted to design a highly interactive meeting that could be attended by a small group of Rheums, to facilitate interaction, collegiality and low stress to optimize learning.  Studies suggest that meetings of 150 or less are the best for learning and interaction.  Yet this will be a big meeting in that we will be drawing attendees from across the nation, tapping into a nationally and internationally reknowned faculty AND beam these 16 hours of high level rheumatology content via the internet to anyone who wants to tune in and register from afar.

The faculty is led by Dr. Artie Kavanaugh (UCSD) and myself (UTSW) and includes our keynote speaker from Aukland, NZ, the fabulous Dr. Nicola Dalbeth who will lecture 3 times on Gout and so much more. We run several 2-hour blocks devoted to RA, PsA, AS/SpA, Lupus and Autoinflammatoy diseases.  In each block we have 3 faculty giving concise, 30-minute lectures and then end with a 30-minute Q&A session with all the faculty.  These are highly engaging and amazingly entertaining.

As if that's not enough, each 2 hour block is broken up with "TED" talks (we call these STEP talks) with major leaders giving short 10-15 minute inspirational talks or minilectures.  STEP sessions include a) the History of Rheumatology (with talks by Dr. Bevra Hahn, Dr. Daniel Wallace, Dr. Dalbeth); b) Masters of the EU (Dr. Gerd Burmester, Dr. Robert Landawe, Dr. Josef Smolen) and c) The Future of Rheumatology Practice (Drs Chad Deal, Alvin Wells, Eric Newman).

This meeting is amazingly unique in that we will hear sessions run by patients - who will give us their perspectives on RA and PsA care. We also have a session from two young leaders in Rheumatology education - they are the podcasters - Drs. Jon Hausmann and Mike Putman.

Come and I'm certain you'll be amazed with our best in class speakers:

  • Atul Deodhar on Advances in SpA therapy
  • Artie Kavanaugh on IBD arthritis
  • Walter Maksymowych on Imaging in SpA
  • Joan Merrill on Lupus Nephritis
  • Megan Clowse on Managing Lupus Pregnancy
  • Melissa Costner on Lupus Skin Disease and Mimics
  • Jon Giles on RA and CV Risk 
  • Christopher Ritchlin on PsA Strategic Approaches
  • Bruce Cronstein on Methotrexate Mechanisms
  • Jack Cush (me) on which is worse - Seronegative or Seropositive RA? 

Go here to register and attend RheumNow Live 2020.

Go here to see the speakers and agenda. 

Next week we will announce how to register for remote viewing of our meeting, but there are still some seats left for the live audience in Fort Worth.  Oh I forgot to mention how cool and gracious Fort Worth is as our host.  The hotel is easy, comfortable  and right in the middle of town. You are 1-5 blocks from scores of resturants and need spots - night and day.  Friday night we will have a great early evening reception on the roof, "RheumNow Distilled".

I think you should be there, I hope you can be, and I look forward to seeing you. 

 

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject
The author has an ownership interest in this subject

Add new comment

More Like This

Incubation Period for COVID-19

The incubation period for coronavirus disease 2019 (COVID-19) has important implications for surveillance and control activities. The Annals of Internal Medicine reports a pooled analysis of confirmed COVID-19 cases January 4, 2020 and February 24, 2020. The analyzed confirmed SARS-CoV-2 infection outside Hubei province, China.

COVID-19 Susceptibility: Why Do Some Become So Ill?

The differential susceptibility to COVID-19 infection is attributable to socioeconomic factors and genetic differences, that together with environmental factors, human-virus interactions, gender, perhaps blood type, and age-related senescence determine the immune response and the likelihood of developing disease.

NICE Guidelines on Managing Rheumatologic Conditions During COVID-19 Pandemic

On April 3rd, the National Institute for Health and Care Excellence (NICE) in the UK, published a rapid guideline for managing children and adults with rheumatological autoimmune, inflammatory and metabolic bone disorders during the COVID-19 pandemic, while protecting staff from infection.

RheumNow Podcast – Pandemic Numbers (4.3.20)

Dr. Jack Cush reviews the news on COVID-19 and FDA actions this past week. Be sure to check out:

CDC: Impact of Underlying Health Conditions Among COVID-19 Patients

The March 31 release of the Morbidity and Mortality Weekly Report (MMWR) reviews the impact of several key comorbidities, most commonly diabetes mellitus, chronic lung disease, and cardiovascular disease, as cofactors leading to worse outcomes with COVID-19 infections.  Below are experts from that report.